Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for KIMS IPO is 44. Their analysis recommends Avoid, However active risk seekers can try for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 44 | Avoid, However active risk seekers can try |
[Dilip Davda] We are witnessing fancy for health care segment following global pandemic and the likely trends of changing lifestyle with health consciousness and spending for the same. This company has ultra-modern equipment and has been posting growth in its top and bottom lines. Investors may consider long term investment in this fully priced offer. Read detail review...
KIMS IPO Reviews, analysis and views by popular members. Read Krishna Institute of Medical Sciences Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP